Table 2 Delphi survey participants, organised by Member State and professional stakeholder group. Individuals with both clinical genetics and clinical oncology qualifications were counted only as clinical geneticists (i.e. their primary practicing specialty).

From: Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study

MEMBER STATE

NUMBER OF PARTICIPANTS

Clinical/medical Geneticist

Clinical/medical Oncologist

Genetic Counsellor

Cancer Patient Organisation

TOTAL

Phase

Phase

Phase

Phase

Phase

I

II

III

I

II

III

I

II

III

I

II

III

I

II

III

Austria

2

2

2

-

-

-

1

1

1

-

-

-

3

3

3

Belgium

2

2

2

1

1

1

3

3

2

-

-

-

6

6

5

Bulgaria

-

-

-

-

-

-

=

=

=

1

1

1

1

1

1

Croatia

-

-

-

-

-

-

=

=

=

1

1

1

1

1

1

Cyprus

-

-

-

1

1

1

1

1

1

1

-

-

3

2

2

Czech Republic

2

2

2

-

-

-

=

=

=

-

-

-

2

2

2

Denmark

2

1

1

-

-

-

1

1

1

1

-

1

4

2

3

Estonia

-

-

-

-

-

-

1

1

1

-

-

-

1

1

1

Finland

2

2

2

-

-

-

=

=

=

1

1

-

3

3

2

France

1

1

1

2

2

2

1

1

1

-

-

-

4

4

4

Germany

2

1

2

1

1

1

1

1

1

-

-

-

4

3

4

Greece

-

-

-

1

1

1

-

-

-

1

1

-

2

2

1

Hungary

2

1

1

-

-

-

=

=

=

1

-

-

3

1

1

Ireland

1

1

1

-

-

-

3

2

2

1

1

1

5

4

4

Italy

2

2

2

1

-

1

-

-

-

1

1

1

4

3

4

Latvia

2

2

2

-

-

-

=

=

=

1

1

1

3

3

3

Lithuania

1

1

1

1

-

-

=

=

=

-

-

-

2

1

1

Luxembourg

1

-

1

-

-

-

1

1

1

1

1

1

3

2

3

Malta

-

-

-

-

-

-

1

1

1

1

1

1

3*

3*

3*

The Netherlands

1

1

1

-

-

-

-

-

-

2

2

2

3

3

3

Poland

1

1

1

1

1

1

=

=

=

-

-

-

2

2

2

Portugal

-

-

-

-

-

-

1

1

1

1

1

1

2

2

2

Romania

2

2

2

1

1

1

1

1

1

1

1

1

5

5

5

Slovakia

1

1

1

1

-

1

=

=

=

-

-

-

2

1

2

Slovenia

1

1

1

1

1

1

=

=

=

-

-

-

2

2

2

Spain

-

-

-

1

1

1

1

1

1

-

-

-

2

2

2

Sweden

1

1

1

-

-

-

1

1

1

-

-

-

2

2

2

TOTAL

29

25

27

13

10

12

18

17

16

16

13

12

77

66

68

  1. Individuals in a leadership position of a national genetics or oncology society but without clinical qualifications were counted in the respective genetics or oncology professional group. Of the 29 clinical/medical geneticists participating in Phase I, 13 were in leadership positions of their national clinical/medical genetics society. Of the 13 clinical/medical oncologists participating in Phase I, 6 were in leadership positions of their national clinical/medical oncology society. * - final numbers include the participation of an otherwise qualified individual. ‘-’ designates that an invitation was sent but no response was received. ‘=’designates that no invitation was sent due to genetic counsellors not being active in the Member State according to the most recent available data.12
Back to article page